Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer.

Gill RK, Yang SH, Meerzaman D, Mechanic LE, Bowman ED, Jeon HS, Roy Chowdhuri S, Shakoori A, Dracheva T, Hong KM, Fukuoka J, Zhang JH, Harris CC, Jen J.

Oncogene. 2011 Sep 1;30(35):3784-91. doi: 10.1038/onc.2011.98. Epub 2011 May 2.

2.

Investigating the genome diversity of B. cereus and evolutionary aspects of B. anthracis emergence.

Papazisi L, Rasko DA, Ratnayake S, Bock GR, Remortel BG, Appalla L, Liu J, Dracheva T, Braisted JC, Shallom S, Jarrahi B, Snesrud E, Ahn S, Sun Q, Rilstone J, Okstad OA, Kolstø AB, Fleischmann RD, Peterson SN.

Genomics. 2011 Jul;98(1):26-39. doi: 10.1016/j.ygeno.2011.03.008. Epub 2011 Apr 5.

3.

TLR signaling is required for Salmonella typhimurium virulence.

Arpaia N, Godec J, Lau L, Sivick KE, McLaughlin LM, Jones MB, Dracheva T, Peterson SN, Monack DM, Barton GM.

Cell. 2011 Mar 4;144(5):675-88. doi: 10.1016/j.cell.2011.01.031.

4.

SMAD6 contributes to patient survival in non-small cell lung cancer and its knockdown reestablishes TGF-beta homeostasis in lung cancer cells.

Jeon HS, Dracheva T, Yang SH, Meerzaman D, Fukuoka J, Shakoori A, Shilo K, Travis WD, Jen J.

Cancer Res. 2008 Dec 1;68(23):9686-92. doi: 10.1158/0008-5472.CAN-08-1083.

5.

Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival.

Landi MT, Dracheva T, Rotunno M, Figueroa JD, Liu H, Dasgupta A, Mann FE, Fukuoka J, Hames M, Bergen AW, Murphy SE, Yang P, Pesatori AC, Consonni D, Bertazzi PA, Wacholder S, Shih JH, Caporaso NE, Jen J.

PLoS One. 2008 Feb 20;3(2):e1651. doi: 10.1371/journal.pone.0001651.

6.

Alpha-methylacyl CoA racemase in pulmonary adenocarcinoma, squamous cell carcinoma, and neuroendocrine tumors: expression and survival analysis.

Shilo K, Dracheva T, Mani H, Fukuoka J, Sesterhenn IA, Chu WS, Shih JH, Jen J, Travis WD, Franks TJ.

Arch Pathol Lab Med. 2007 Oct;131(10):1555-60.

PMID:
17922592
7.

Systematic analysis of genetic alterations in tumors using Cancer Genome WorkBench (CGWB).

Zhang J, Finney RP, Rowe W, Edmonson M, Yang SH, Dracheva T, Jen J, Struewing JP, Buetow KH.

Genome Res. 2007 Jul;17(7):1111-7. Epub 2007 May 24.

8.

Inactivation of LLC1 gene in nonsmall cell lung cancer.

Hong KM, Yang SH, Chowdhuri SR, Player A, Hames M, Fukuoka J, Meerzaman D, Dracheva T, Sun Z, Yang P, Jen J.

Int J Cancer. 2007 Jun 1;120(11):2353-8.

9.

Distinguishing lung tumours from normal lung based on a small set of genes.

Dracheva T, Philip R, Xiao W, Gee AG, McCarthy J, Yang P, Wang Y, Dong G, Yang H, Jen J.

Lung Cancer. 2007 Feb;55(2):157-64. Epub 2006 Dec 8.

10.

Desmoglein 3 as a prognostic factor in lung cancer.

Fukuoka J, Dracheva T, Shih JH, Hewitt SM, Fujii T, Kishor A, Mann F, Shilo K, Franks TJ, Travis WD, Jen J.

Hum Pathol. 2007 Feb;38(2):276-83. Epub 2006 Nov 3.

PMID:
17084439
11.

Mutations in the tyrosine kinase domain of the epidermal growth factor receptor in non-small cell lung cancer.

Yang SH, Mechanic LE, Yang P, Landi MT, Bowman ED, Wampfler J, Meerzaman D, Hong KM, Mann F, Dracheva T, Fukuoka J, Travis W, Caporaso NE, Harris CC, Jen J.

Clin Cancer Res. 2005 Mar 15;11(6):2106-10. Erratum in: Clin Cancer Res. 2005 Nov 1;11(21):7960-1.

12.

Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.

Fukuoka J, Fujii T, Shih JH, Dracheva T, Meerzaman D, Player A, Hong K, Settnek S, Gupta A, Buetow K, Hewitt S, Travis WD, Jen J.

Clin Cancer Res. 2004 Jul 1;10(13):4314-24.

13.

Identification of TDE2 gene and its expression in non-small cell lung cancer.

Player A, Gillespie J, Fujii T, Fukuoka J, Dracheva T, Meerzaman D, Hong KM, Curran J, Attoh G, Travis W, Jen J.

Int J Cancer. 2003 Nov 1;107(2):238-43.

14.

Profiling lung adenocarcinoma: insights from genes and more genes.

Dracheva T, Jen J.

Cancer Biol Ther. 2003 May-Jun;2(3):299-300. No abstract available.

PMID:
12878870
15.

DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development.

Wu G, Nomoto S, Hoque MO, Dracheva T, Osada M, Lee CC, Dong SM, Guo Z, Benoit N, Cohen Y, Rechthand P, Califano J, Moon CS, Ratovitski E, Jen J, Sidransky D, Trink B.

Cancer Res. 2003 May 15;63(10):2351-7.

16.

A preliminary transcriptome map of non-small cell lung cancer.

Fujii T, Dracheva T, Player A, Chacko S, Clifford R, Strausberg RL, Buetow K, Azumi N, Travis WD, Jen J.

Cancer Res. 2002 Jun 15;62(12):3340-6.

17.

Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells.

Kim JS, Crooks H, Dracheva T, Nishanian TG, Singh B, Jen J, Waldman T.

Cancer Res. 2002 May 15;62(10):2744-8.

18.

Molecular characteristics of non-small cell lung cancer.

Nacht M, Dracheva T, Gao Y, Fujii T, Chen Y, Player A, Akmaev V, Cook B, Dufault M, Zhang M, Zhang W, Guo M, Curran J, Han S, Sidransky D, Buetow K, Madden SL, Jen J.

Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15203-8.

19.

Site inhomogeneity and exciton delocalization in the photosynthetic antenna.

Dracheva TV, Novoderezhkin VI, Razjivin AP.

Photosynth Res. 1996 Sep;49(3):269-76. doi: 10.1007/BF00034788.

PMID:
24271705
20.

Supplemental Content

Loading ...
Support Center